Afzal, S., Abdul Manap, A
For weekly semaglutide, steady state is generally achieved after 4 to 5 weeks of consistent dosing, while liraglutide reaches steady state within 3 to 5 days due to its shorter half-life (approximately 13 hours)
Studies indicate that around 90% of patients with hEDS experience gastrointestinal challenges that can include reflux, slow gastric emptying, low motility, dysphagia (trouble swallowing), gastroparesis, constipation, IBS and functional dyspepsia, which is characterised as pain or discomfort in the upper abdomen, bloating, belching, nausea, and an unusual feeling of fullness after meals (4,6,7,11)
In fact, more than 90% of people suffer from them
Research surrounding Epithalon focuses on its potential influence on telomerase activity, circadian rhythms, and healthy aging pathways
That makes it less irritating than other glycolic acid formulas